University honour for CEO
THE Manchester-born chief executive of a pharmaceuticals company has returned to the city to receive an honorary doctorate recognising his contribution to the industry.
Paul Hudson, chief executive of Novartis Pharmaceuticals, completed an economics degree at Manchester Metropolitan University almost 30 years ago.
Now he been named an honorary Doctor of Business Administration.
Mr Hudson, who graduated from Manchester Metropolitan in 1990 with a BA (Hons) in Economics, now oversees a workforce of 30,000 for the Novartis Pharmaceuticals unit, which commercialises innovative patent-protected medicines to enhance health outcomes for patients and healthcare providers.
After completing his degree, Mr Hudson began a career in the pharmaceutical sector with roles in sales and marketing, holding positions of increasing responsibilities at different companies in various countries and being appointed CEO at Novartis Pharmaceuticals two years ago.
Mr Hudson said: “For me, my time at Manchester Metropolitan University was a gift. It gave me some inspiring lecturers, people that stimulated my thinking and made me curious and energised and made me interested in business, in economics, in global opportunities, and in making things fair and equitable worldwide.”